1-4 of 4
Robert Crowder
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor–Positive Metastatic Breast Cancer

Cynthia X. Ma, Cesar Sanchez, Feng Gao, Robert Crowder, Michael Naughton, Timothy Pluard, Allison Creekmore, Zhanfang Guo, Jeremy Hoog, A. Craig Lockhart, Austin Doyle, Charles Erlichman, Matthew J. Ellis
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (11): 2650–2658.
https://doi.org/10.1158/1078-0432.CCR-15-2160
Published: 31 May 2016
View article titled, A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor–Positive Metastatic Breast Cancer
Open the PDF for A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor–Positive Metastatic Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy–Resistant Breast Cancer

Suzanne E. Wardell, Matthew J. Ellis, Holly M. Alley, Koleen Eisele, Todd VanArsdale, Stephen G. Dann, Kim T. Arndt, Tina Primeau, Elizabeth Griffin, Jieya Shao, Robert Crowder, Jin-Ping Lai, John D. Norris, Donald P. McDonnell, Shunqiang Li
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (22): 5121–5130.
https://doi.org/10.1158/1078-0432.CCR-15-0360
Published: 12 November 2015
View article titled, Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy–Resistant Breast Cancer
Open the PDF for Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy–Resistant Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract IA3: PI3K inhibitors in ER+ breast cancer: Next steps

Matthew J. Ellis, Robert Crowder, Cynthia X. Ma
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (10_Supplement): IA3.
https://doi.org/10.1158/1078-0432.MECHRES-IA3
Published: 04 March 2013
View article titled, Abstract IA3: PI3K inhibitors in ER+ breast cancer: Next steps
Open the PDF for Abstract IA3: PI3K inhibitors in ER+ breast cancer: Next steps in another window
Journal Articles

“PIKing” the Winner for Phosphatidylinositol 3-Kinase Inhibitors in ErbB2-Positive Breast Cancer: Let's Not “PTENed” It's Easy!

Matthew J. Ellis, Robert Crowder
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19): 5661–5662.
https://doi.org/10.1158/1078-0432.CCR-07-1698
Published: 01 October 2007
View article titled, “PIKing” the Winner for Phosphatidylinositol 3-Kinase Inhibitors in ErbB2-Positive Breast Cancer: Let's Not “PTENed” It's Easy!
Open the PDF for “PIKing” the Winner for Phosphatidylinositol 3-Kinase Inhibitors in ErbB2-Positive Breast Cancer: Let's Not “PTENed” It's Easy! in another window